Clinical trial
Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
NCT00282360 · IRCCS San Raffaele, Other · Completed
Key facts
| NCT number | NCT00282360 |
|---|---|
| Title | Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease |
| Official title | Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease |
| Lead sponsor | IRCCS San Raffaele, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Type II Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Trimetazidine |
| Enrollment | 30 |
| Start date | Feb 1, 1999 |
| Completion | Oct 1, 2003 |
| First posted | Jan 26, 2006 |
| Last update posted | Jan 26, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: